Pier Capital LLC boosted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 88.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 231,884 shares of the company's stock after buying an additional 108,783 shares during the period. Pier Capital LLC owned 0.14% of Option Care Health worth $7,258,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds also recently bought and sold shares of OPCH. SG Americas Securities LLC lifted its holdings in Option Care Health by 619.3% during the second quarter. SG Americas Securities LLC now owns 60,356 shares of the company's stock worth $1,672,000 after buying an additional 51,965 shares during the period. Blue Trust Inc. lifted its holdings in shares of Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock valued at $81,000 after purchasing an additional 377 shares during the last quarter. Raymond James & Associates lifted its holdings in shares of Option Care Health by 49.5% during the 2nd quarter. Raymond James & Associates now owns 80,230 shares of the company's stock valued at $2,222,000 after purchasing an additional 26,560 shares during the last quarter. Leeward Investments LLC MA purchased a new position in Option Care Health in the 2nd quarter worth $12,044,000. Finally, Lifestyle Asset Management Inc. raised its stake in Option Care Health by 32.0% in the 2nd quarter. Lifestyle Asset Management Inc. now owns 8,292 shares of the company's stock worth $230,000 after acquiring an additional 2,009 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.
Insider Activity
In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the company's stock in a transaction dated Friday, November 8th. The shares were purchased at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the transaction, the director now directly owns 326,334 shares of the company's stock, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.64% of the company's stock.
Wall Street Analyst Weigh In
A number of brokerages recently issued reports on OPCH. Barrington Research reduced their target price on Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a research note on Thursday, October 31st. UBS Group began coverage on Option Care Health in a research note on Thursday. They issued a "neutral" rating and a $26.00 target price for the company. Truist Financial reduced their target price on Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a research note on Friday, November 1st. Jefferies Financial Group lowered Option Care Health from a "buy" rating to a "hold" rating and reduced their target price for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Finally, Bank of America lowered Option Care Health from a "buy" rating to a "neutral" rating and reduced their target price for the stock from $43.00 to $29.00 in a research note on Wednesday, October 30th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $30.14.
View Our Latest Research Report on Option Care Health
Option Care Health Stock Performance
OPCH traded up $0.13 during midday trading on Friday, hitting $22.85. 1,166,475 shares of the company were exchanged, compared to its average volume of 2,120,894. The company's 50 day simple moving average is $26.04 and its 200 day simple moving average is $28.66. The firm has a market capitalization of $3.89 billion, a price-to-earnings ratio of 19.20, a price-to-earnings-growth ratio of 2.45 and a beta of 1.33. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $34.63.
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
